J2 Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$417K Buy
5,973
+37
+0.6% +$2.62K 0.53% 49
2023
Q2
$410K Buy
5,936
+669
+13% +$47.6K 0.49% 52
2023
Q1
$391K Buy
5,267
+1,060
+25% +$88.9K 0.61% 42
2022
Q4
$392K Buy
4,207
+206
+5% +$19.9K 0.67% 36
2022
Q3
$382K Buy
4,001
+248
+7% +$24.5K 0.72% 28
2022
Q2
$348K Buy
3,753
+119
+3% +$11.6K 0.53% 40
2022
Q1
$368K Sell
3,634
-822
-18% -$86.4K 0.4% 49
2021
Q4
$460K Buy
+4,456
New +$412K 0.44% 38

Other funds holding CVS

J2 Capital Management's CVS Position: Q3 2023 in Review

J2 Capital Management increased its CVS Health (CVS) stake by 0.62% in Q3 2023, buying an estimated $2.62K and bringing the position to 5,973 shares worth $417K. The position accounts for 0.53% of the portfolio, ranked #49.

J2 Capital Management first reported a position in CVS in Q4 2021 and has held it in 8 quarters since. The position peaked at $460K in Q4 2021. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • J2 Capital Management held 5,973 shares of CVS Health worth $417K as of Q3 2023.
  • J2 Capital Management bought 37 CVS Health shares in Q3 2023, an estimated $2.62K.
  • CVS Health made up 0.53% of J2 Capital Management's portfolio in Q3 2023, its #49 holding.
  • J2 Capital Management first reported a position in CVS Health in Q4 2021 and has held it in 8 quarters since.
  • J2 Capital Management's CVS Health position peaked at $460K in Q4 2021.
  • 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on J2 Capital Management's 13F filing for Q3 2023, filed 11 Oct 2023.